|
1
|
Willis RA: The Spread of Tumors in the
Human Body. 3rd edition. Butterworths; London: 1973
|
|
2
|
Reiche EM, Nunes SO and Morimoto HK:
Stress, depression, the immune system, and cancer. Lancet Oncol.
5:617–625. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lutgendorf SK and Sood AK: Biobehavioral
factors and cancer progression: physiological pathways and
mechanisms. Psychosom Med. 73:724–730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Thaker PH and Sood AK: Neuroendocrine
influences on cancer biology. Semin Cancer Biol. 18:164–170. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Armaiz-Pena GN, Lutgendorf SK, Cole SW and
Sood AK: Neuroendocrine modulation of cancer progression. Brain
Behav Immun. 23:10–15. 2009. View Article : Google Scholar
|
|
6
|
Williams JB, Pang D, Delgado B,
Kocherginsky M, Tretiakova M, Krausz T, Pan D, He J, McClintock MK
and Conzen SD: A model of gene-environment interaction reveals
altered mammary gland gene expression and increased tumor growth
following social isolation. Cancer Prev Res (Phila). 2:850–861.
2009. View Article : Google Scholar
|
|
7
|
McEwen BS: Physiology and neurobiology of
stress and adaptation: central role of the brain. Physiol Rev.
87:873–904. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Toh YC: Inhibitory effect of hypothalamic
lesions on liver tumor induction by N-2-fluorenylacetamide in male
rats. Cancer Res. 38:42–51. 1978.PubMed/NCBI
|
|
9
|
Karasek M and Pawlikowski M: Pineal gland,
melatonin and cancer. NEL Review. Neuro Endocrinol Lett.
20:139–144. 1999.PubMed/NCBI
|
|
10
|
Bruni JE and Montemurro DG: Effect of
hypothalamic lesions on the genesis of spontaneous mammary gland
tumors in the mouse. Cancer Res. 31:854–863. 1971.PubMed/NCBI
|
|
11
|
Chelmicka-Szorc E and Arnason BG: Effect
of 6-hydroxydopamine on tumor growth. Cancer Res. 36:2382–2384.
1976.PubMed/NCBI
|
|
12
|
Chelmicka-Schorr E and Arnason BG:
Modulatory effect of the sympathetic nervous system on
neuroblastoma tumor growth. Cancer Res. 38:1374–1375.
1978.PubMed/NCBI
|
|
13
|
Seifert P and Spitznas M: Tumours may be
innervated. Virchows Arch. 438:228–231. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seifert P, Benedic M and Effert P: Nerve
fibers in tumors of the human urinary bladder. Virchows Arch.
440:291–297. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu SH, Zhou Y, Que HP and Liu SJ:
Peptidergic innervation of human esophageal and cardiac carcinoma.
World J Gastroenterol. 9:399–403. 2003.PubMed/NCBI
|
|
16
|
Liang YJ, Zhou P, Wongba W, Guardiola J,
Walker J and Yu J: Pulmonary innervation, inflammation and
carcinogenesis. Sheng Li Xue Bao. 62:191–195. 2010.PubMed/NCBI
|
|
17
|
Li JH, Ma QY, Shen SG and Hu HT:
Stimulation of dorsal root ganglion neurons activity by pancreatic
cancer cell lines. Cell Biol Int. 32:1530–1535. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Albo D, Akay CL, Marshall CL, Wilks JA,
Verstovsek G, Liu H, Agarwal N, Berger DH and Ayala GE:
Neurogenesis in colorectal cancer is a marker of aggressive tumor
behavior and poor outcomes. Cancer. 117:4834–4845. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ayala GE, Wheeler TM, Shine HD, Schmelz M,
Frolov A, Chakraborty S and Rowley D: In vitro dorsal root ganglia
and human prostate cell line interaction: redefining perineural
invasion in prostate cancer. Prostate. 49:213–223. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Batkin S, Piette LH and Wildman E: Effect
of muscle denervation on growth of transplanted tumor in mice. Proc
Natl Acad Sci USA. 67:1521–1527. 1970. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Papageorgiou A, Trontzos C, Kallistratos
H, Kokkas B, Grigoriadis N and Grammaticos P: Slowing growth and
histology changes in Lewis lung carcinoma implanted in a partly
denervated muscle. Cancer Invest. 21:869–872. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Romeo HE, Colombo LL, Esquifino AI,
Rosenstein RE, Chuluyan HE and Cardinali DP: Slower growth of
tumours in sympathetically denervated murine skin. J Auton Nerv
Syst. 32:159–164. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peng J, Sheng W, Huang D, Venook AP, Xu Y,
Guan Z and Cai S: Perineural invasion in pT3N0 rectal cancer: the
incidence and its prognostic effect. Cancer. 117:1415–1421. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feng FY, Qian Y, Stenmark MH, Halverson S,
Blas K, Vance S, Sandler HM and Hamstra DA: Perineural invasion
predicts increased recurrence, metastasis, and death from prostate
cancer following treatment with dose-escalated radiation therapy.
Int J Radiat Oncol Biol Phys. 81:e361–e367. 2011. View Article : Google Scholar
|
|
25
|
Poeschl EM, Pollheimer MJ, Kornprat P,
Lindtner RA, Schlemmer A, Rehak P, Vieth M and Langner C:
Perineural invasion: correlation with aggressive phenotype and
independent prognostic variable in both colon and rectum cancer. J
Clin Oncol. 28:e358–e360. e361–e362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liebig C, Ayala G, Wilks JA, Berger DH and
Albo D: Perineural invasion in cancer: a review of the literature.
Cancer. 115:3379–3391. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Khasraw M and Posner JB: Neurological
complications of systemic cancer. Lancet Neurol. 9:1214–1227. 2010.
View Article : Google Scholar
|
|
28
|
Toothaker TB and Rubin M: Paraneoplastic
neurological syndromes: a review. Neurologist. 15:21–33. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mravec B, Gidron Y and Hulin I:
Neurobiology of cancer: Interactions between nervous, endocrine and
immune systems as a base for monitoring and modulating the
tumorigenesis by the brain. Semin Cancer Biol. 18:150–163. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Entschladen F, Palm D, Niggemann B and
Zaenker KS: The cancer's nervous tooth: Considering the neuronal
crosstalk within tumors. Semin Cancer Biol. 18:171–175. 2008.
|
|
31
|
Ondicova K and Mravec B: Role of nervous
system in cancer aetiopathogenesis. Lancet Oncol. 11:596–601. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sloan EK, Priceman SJ, Cox BF, Yu S,
Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas
BD, Wu L, Sood AK and Cole SW: The sympathetic nervous system
induces a metastatic switch in primary breast cancer. Cancer Res.
70:7042–7052. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gupta GP and Massague J: Cancer
metastasis: building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
de Visser KE, Eichten A and Coussens LM:
Paradoxical roles of the immune system during cancer development.
Nat Rev Cancer. 6:24–37. 2006.
|
|
35
|
DeNardo DG, Johansson M and Coussens LM:
Immune cells as mediators of solid tumor metastasis. Cancer
Metastasis Rev. 27:11–18. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu Y and Zhou BP: Inflammation: a driving
force speeds cancer metastasis. Cell Cycle. 8:3267–3273. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Solinas G, Marchesi F, Garlanda C,
Mantovani A and Allavena P: Inflammation-mediated promotion of
invasion and metastasis. Cancer Metastasis Rev. 29:243–248. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nguyen DX, Bos PD and Massague J:
Metastasis: from dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sung SY, Hsieh CL, Wu D, Chung LW and
Johnstone PA: Tumor microenvironment promotes cancer progression,
metastasis, and therapeutic resistance. Curr Probl Cancer.
31:36–100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Calorini L and Bianchini F: Environmental
control of invasiveness and metastatic dissemination of tumor
cells: the role of tumor cell-host cell interactions. Cell Commun
Signal. 8:242010.PubMed/NCBI
|
|
41
|
Shapiro DM and Warren S: Cancer
innervation. Cancer Res. 9:707–711. 1949.
|
|
42
|
Mitchell BS, Schumacher U, Stauber VV and
Kaiserling E: Are breast tumours innervated? Immunohistological
investigations using antibodies against the neuronal marker protein
gene product 95 (PGP 95) in benign and malignant breast lesions.
Eur J Cancer. 30A:1100–1103. 1994. View Article : Google Scholar
|
|
43
|
Seifert P and Spitznas M: Axons in human
choroidal melanoma suggest the participation of nerves in the
control of these tumors. Am J Ophthalmol. 133:711–713. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Feng F, Yang J, Tong L, Yuan S, Tian Y,
Hong L, Wang W and Zhang H: Substance P immunoreactive nerve fibres
are related to gastric cancer differentiation status and could
promote proliferation and migration of gastric cancer cells. Cell
Biol Int. 35:623–629. 2011. View Article : Google Scholar
|
|
45
|
Gidron Y, Perry H and Glennie M: Does the
vagus nerve inform the brain about preclinical tumours and modulate
them? Lancet Oncol. 6:245–248. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Erin N, Boyer PJ, Bonneau RH, Clawson GA
and Welch DR: Capsaicin-mediated denervation of sensory neurons
promotes mammary tumor metastasis to lung and heart. Anticancer
Res. 24:1003–1009. 2004.PubMed/NCBI
|
|
47
|
Erin N, Akdas BG, Harms JF and Clawson GA:
Vagotomy enhances experimental metastases of 4THMpc breast cancer
cells and alters substance P level. Regul Pept. 151:35–42. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Palm D and Entschladen F: Neoneurogenesis
and the neuroneoplastic synapse. Prog Exp Tumor Res. 39:91–98.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zanker KS: The neuro-neoplastic synapse:
does it exist? Prog Exp Tumor Res. 39:154–161. 2007.PubMed/NCBI
|
|
50
|
Varner JA: Stem cells and neurogenesis in
tumors. Prog Exp Tumor Res. 39:122–129. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ayala GE, Dai H, Powell M, Li R, Ding Y,
Wheeler TM, Shine D, Kadmon D, Thompson T, Miles BJ, Ittmann MM and
Rowley D: Cancer-related axonogenesis and neurogenesis in prostate
cancer. Clin Cancer Res. 14:7593–7603. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mitchell BS, Schumacher U and Kaiserling
E: Are tumours innervated? Immunohistological investigations using
antibodies against the neuronal marker protein gene product 95 (PGP
95) in benign, malignant and experimental tumours. Tumour Biol.
15:269–274. 1994. View Article : Google Scholar
|
|
53
|
Terada T and Matsunaga Y: S-100-positive
nerve fibers in hepatocellular carcinoma and intrahepatic
cholangiocarcinoma: an immunohistochemical study. Pathol Int.
51:89–93. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Pollak M, Sem AW, Richard M, Tetenes E and
Bell R: Inhibition of metastatic behavior of murine osteosarcoma by
hypophysectomy. J Natl Cancer Inst. 84:966–971. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Giraldi T, Perissin L, Zorzet S, Rapozzi V
and Rodani MG: Metastasis and neuroendocrine system in stressed
mice. Int J Neurosci. 74:265–278. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Marchetti B, Spinola PG, Pelletier G and
Labrie F: A potential role for catecholamines in the development
and progression of carcinogen-induced mammary tumors: hormonal
control of beta-adrenergic receptors and correlation with tumor
growth. J Steroid Biochem Mol Biol. 38:307–320. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Fava G, Marucci L, Glaser S, Francis H, De
Morrow S, Benedetti A, Alvaro D, Venter J, Meininger C, Patel T,
Taffetani S, Marzioni M, Summers R, Reichenbach R and Alpini G:
Gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by
cyclic AMP-dependent regulation of the protein kinase
A/extracellular signal-regulated kinase 1/2 pathway. Cancer Res.
65:11437–11446. 2005. View Article : Google Scholar
|
|
58
|
Al-Wadei HA, Plummer HK III and Schuller
HM: Nicotine stimulates pancreatic cancer xenografts by systemic
increase in stress neurotransmitters and suppression of the
inhibitory neurotransmitter gamma-aminobutyric acid.
Carcinogenesis. 30:506–511. 2009. View Article : Google Scholar
|
|
59
|
Yamanaka Y, Mammoto T, Kirita T, Mukai M,
Mashimo T, Sugimura M, Kishi Y and Nakamura H: Epinephrine inhibits
invasion of oral squamous carcinoma cells by modulating
intra-cellular cAMP. Cancer Lett. 176:143–148. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang T, Huang W and Chen F: Baclofen, a
GABAB receptor agonist, inhibits human hepatocellular carcinoma
cell growth in vitro and in vivo. Life Sci. 82:536–541. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ellis LM: The role of neuropilins in
cancer. Mol Cancer Ther. 5:1099–1107. 2006. View Article : Google Scholar
|
|
62
|
Rizzolio S and Tamagnone L: Multifaceted
role of neuropilins in cancer. Curr Med Chem. 18:3563–3575. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kreuter M, Bielenberg D, Hida Y, Hida K
and Klagsbrun M: Role of neuropilins and semaphorins in
angiogenesis and cancer. Ann Hematol. 81(Suppl 2):
S742002.PubMed/NCBI
|
|
64
|
Chedotal A, Kerjan G and Moreau-Fauvarque
C: The brain within the tumor: new roles for axon guidance
molecules in cancers. Cell Death Differ. 12:1044–1056. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Nakagawara A: Trk receptor tyrosine
kinases: a bridge between cancer and neural development. Cancer
Lett. 169:107–114. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wong HP, Ho JW, Koo MW, Yu L, Wu WK, Lam
EK, Tai EK, Ko JK, Shin VY, Chu KM and Cho CH: Effects of
adrenaline in human colon adenocarcinoma HT-29 cells. Life Sci.
88:1108–1112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Marin YE and Chen S: Involvement of
metabotropic glutamate receptor 1, a G protein coupled receptor, in
melanoma development. J Mol Med (Berl). 82:735–749. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Castro-Rivera E, Ran S, Brekken RA and
Minna JD: Semaphorin 3B inhibits the phosphatidylinositol
3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer
cells. Cancer Res. 68:8295–8303. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kigel B, Varshavsky A, Kessler O and
Neufeld G: Successful inhibition of tumor development by specific
class-3 semaphorins is associated with expression of appropriate
semaphorin receptors by tumor cells. PLoS One. 3:e32872008.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Pisick E, Jagadeesh S and Salgia R:
Receptor tyrosine kinases and inhibitors in lung cancer. Scientific
World Journal. 4:589–604. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Muller JM: Potential inhibition of the
neuro-neoplastic interactions: the clue of a GPCR-targeted therapy.
Prog Exp Tumor Res. 39:130–153. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Fitzgerald PJ: Is norepinephrine an
etiological factor in some types of cancer? Int J Cancer.
124:257–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Cole SW and Sood AK: Molecular pathways:
beta-adrenergic signaling pathways in cancer. Clin Cancer Res.
18:1201–1206. 2011. View Article : Google Scholar
|
|
74
|
Al-Wadei HA, Plummer HK III, Ullah MF,
Unger B, Brody JR and Schuller HM: Social stress promotes and
γ-aminobutyric acid inhibits tumor growth in mouse models of
non-small cell lung cancer. Cancer Prev Res (Phila). 5:189–196.
2012.
|
|
75
|
Casazza A, Kigel B, Maione F, Capparuccia
L, Kessler O, Giraudo E, Mazzone M, Neufeld G and Tamagnone L:
Tumour growth inhibition and anti-metastatic activity of a mutated
furin-resistant Semaphorin 3E isoform. EMBO Mol Med. 4:234–250.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Erin N, Zhao W, Bylander J, Chase G and
Clawson G: Capsaicin-induced inactivation of sensory neurons
promotes a more aggressive gene expression phenotype in breast
cancer cells. Breast Cancer Res Treat. 99:351–364. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Nasarre P, Potiron V, Drabkin H and Roche
J: Guidance molecules in lung cancer. Cell Adh Migr. 4:130–145.
2010. View Article : Google Scholar
|
|
78
|
Weick A and Augustin HG: Double attack on
tumors by targeting with guidance molecules. Arterioscler Thromb
Vasc Biol. 31:721–722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Bernet A and Fitamant J: Netrin-1 and its
receptors in tumour growth promotion. Expert Opin Ther Targets.
12:995–1007. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Schuller HM and Al-Wadei HA:
Neurotransmitter receptors as central regulators of pancreatic
cancer. Future Oncol. 6:221–228. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Novotny A, Ryberg K, Heiman UJ, Nilsson L,
Khorram-Manesh A, Nordgren S, Delbro DS and Nylund G: Is
acetylcholine a signaling molecule for human colon cancer
progression? Scand J Gastroenterol. 46:446–455. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Al-Wadei HA, Al-Wadei MH and Schuller HM:
Cooperative regulation of non-small cell lung carcinoma by
nicotinic and beta-adrenergic receptors: a novel target for
intervention. PLoS One. 7:e299152012. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Al-Wadei HA, Ullah MF and Al-Wadei M: GABA
(γ-aminobutyric acid), a non-protein amino acid counters the
β-adrenergic cascade-activated oncogenic signaling in pancreatic
cancer: a review of experimental evidence. Mol Nutr Food Res.
55:1745–1758. 2011.
|
|
84
|
Neufeld G, Shraga-Heled N, Lange T,
Guttmann-Raviv N, Herzog Y and Kessler O: Semaphorins in cancer.
Front Biosci. 10:751–760. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
85
|
Rizzolio S and Tamagnone L: Semaphorin
signals on the road to cancer invasion and metastasis. Cell Adh
Migr. 1:62–68. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Chen C, Li M, Chai H, Yang H, Fisher WE
and Yao Q: Roles of neuropilins in neuronal development,
angiogenesis, and cancers. World J Surg. 29:271–275. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Baba T, Kariya M, Higuchi T, Mandai M,
Matsumura N, Kondoh E, Miyanishi M, Fukuhara K, Takakura K and
Fujii S: Neuropilin-1 promotes unlimited growth of ovarian cancer
by evading contact inhibition. Gynecol Oncol. 105:703–711. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Warrington RJ and Lewis KE: Natural
antibodies against nerve growth factor inhibit in vitro prostate
cancer cell metastasis. Cancer Immunol Immunother. 60:187–195.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Arakawa H: Netrin-1 and its receptors in
tumorigenesis. Nat Rev Cancer. 4:978–987. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Kalariti N, Pissimissis N and Koutsilieris
M: The glutamatergic system outside the CNS and in cancer biology.
Expert Opin Investig Drugs. 14:1487–1496. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Watanabe M, Maemura K, Oki K, Shiraishi N,
Shibayama Y and Katsu K: Gamma-aminobutyric acid (GABA) and cell
proliferation: focus on cancer cells. Histol Histopathol.
21:1135–1141. 2006.PubMed/NCBI
|
|
92
|
Chang HJ, Yoo BC, Lim SB, Jeong SY, Kim WH
and Park JG: Metabotropic glutamate receptor 4 expression in
colorectal carcinoma and its prognostic significance. Clin Cancer
Res. 11:3288–3295. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Park SY, Lee SA, Han IH, Yoo BC, Lee SH,
Park JY, Cha IH, Kim J and Choi SW: Clinical significance of
metabotropic glutamate receptor 5 expression in oral squamous cell
carcinoma. Oncol Rep. 17:81–87. 2007.PubMed/NCBI
|
|
94
|
Palma C: Tachykinins and their receptors
in human malignancies. Curr Drug Targets. 7:1043–1052. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Ruscica M, Dozio E, Motta M and Magni P:
Relevance of the neuropeptide Y system in the biology of cancer
progression. Curr Top Med Chem. 7:1682–1691. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Chatikhine VA, Delpech B, Duval C, Chauzy
C, D'Aniou J and Chevrier A: Expression of beta-endorphin in human
breast cancer and adenofibromas. Ann NY Acad Sci. 680:473–475.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Sarkar DK, Zhang C, Murugan S, Dokur M,
Boyadjieva NI, Ortiguela M, Reuhl KR and Mojtehedzadeh S:
Transplantation of beta-endorphin neurons into the hypothalamus
promotes immune function and restricts the growth and metastasis of
mammary carcinoma. Cancer Res. 71:6282–6291. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Mancino M, Ametller E, Gascon P and
Almendro V: The neuronal influence on tumor progression. Biochim
Biophys Acta. 1816:105–118. 2011.PubMed/NCBI
|
|
99
|
MacDougall JR and Matrisian LM:
Contributions of tumor and stromal matrix metalloproteinases to
tumor progression, invasion and metastasis. Cancer Metastasis Rev.
14:351–362. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar
|
|
101
|
Wu W, Yamaura T, Murakami K, Ogasawara M,
Hayashi K, Murata J and Saiki I: Involvement of TNF-alpha in
enhancement of invasion and metastasis of colon 26-L5 carcinoma
cells in mice by social isolation stress. Oncol Res. 11:461–469.
1999.PubMed/NCBI
|
|
102
|
Yang EV, Bane CM, MacCallum RC,
Kiecolt-Glaser JK, Malarkey WB and Glaser R: Stress-related
modulation of matrix metalloproteinase expression. J Neuroimmunol.
133:144–150. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Yao J, Xiong S, Klos K, Nguyen N, Grijalva
R, Li P and Yu D: Multiple signaling pathways involved in
activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1
in human breast cancer cells. Oncogene. 20:8066–8074. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Okada Y, Eibl G, Guha S, Duffy JP, Reber
HA and Hines OJ: Nerve growth factor stimulates MMP-2 expression
and activity and increases invasion by human pancreatic cancer
cells. Clin Exp Metastasis. 21:285–292. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Okada Y, Eibl G, Duffy JP, Reber HA and
Hines OJ: Glial cell-derived neurotrophic factor upregulates the
expression and activation of matrix metalloproteinase-9 in human
pancreatic cancer. Surgery. 134:293–299. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Menter DG, Herrmann JL and Nicolson GL:
The role of trophic factors and autocrine/paracrine growth factors
in brain metastasis. Clin and Exp Metastasis. 13:67–88. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Yang EV, Sood AK, Chen M, Li Y, Eubank TD,
Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S and
Glaser R: Norepinephrine up-regulates the expression of vascular
endothelial growth factor, matrix metalloproteinase (MMP)-2, and
MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res.
66:10357–10364. 2006. View Article : Google Scholar
|
|
108
|
Azuma H, Inamoto T, Sakamoto T, Kiyama S,
Ubai T, Shinohara Y, Maemura K, Tsuji M, Segawa N, Masuda H,
Takahara K, Katsuoka Y and Watanabe M: Gamma-aminobutyric acid as a
promoting factor of cancer metastasis; induction of matrix
metalloproteinase production is potentially its underlying
mechanism. Cancer Res. 63:8090–8096. 2003.
|
|
109
|
Simpson CD, Anyiwe K and Schimmer AD:
Anoikis resistance and tumor metastasis. Cancer Lett. 272:177–185.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Douma S, Van Laar T, Zevenhoven J,
Meuwissen R, Van Garderen E and Peeper DS: Suppression of anoikis
and induction of metastasis by the neurotrophic receptor TrkB.
Nature. 430:1034–1039. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Geiger TR and Peeper DS: The neurotrophic
receptor TrkB in anoikis resistance and metastasis: a perspective.
Cancer Res. 65:7033–7036. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Geiger TR and Peeper DS: Critical role for
TrkB kinase function in anoikis suppression, tumorigenesis, and
metastasis. Cancer Res. 67:6221–6229. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Strizzi L, Bianco C, Raafat A, Abdallah W,
Chang C, Raafat D, Hirota M, Hamada S, Sun Y, Normanno N, Callahan
R, Hinck L and Salomon D: Netrin-1 regulates invasion and migration
of mouse mammary epithelial cells overexpressing Cripto-1 in vitro
and in vivo. J Cell Sci. 118:4633–4643. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Christensen C, Ambartsumian N, Gilestro G,
Thomsen B, Comoglio P, Tamagnone L, Guldberg P and Lukanidin E:
Proteolytic processing converts the repelling signal Sema3E into an
inducer of invasive growth and lung metastasis. Cancer Res.
65:6167–6177. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Kruger RP, Aurandt J and Guan KL:
Semaphorins command cells to move. Nat Rev Mol Cell Biol.
6:789–800. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Kim HK, Zhang H, Li H, Wu TT, Swisher S,
He D, Wu L, Xu J, Elmets CA, Athar M, Xu XC and Xu H: Slit2
inhibits growth and metastasis of fibrosarcoma and squamous cell
carcinoma. Neoplasia. 10:1411–1420. 2008.PubMed/NCBI
|
|
117
|
Casazza A, Finisguerra V, Capparuccia L,
Camperi A, Swiercz JM, Rizzolio S, Rolny C, Christensen C, Bertotti
A, Sarotto I, Risio M, Trusolino L, Weitz J, Schneider M, Mazzone
M, Comoglio PM and Tamagnone L: Sema3E-Plexin D1 signaling drives
human cancer cell invasiveness and meta-static spreading in mice. J
Clin Invest. 120:2684–2698. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Entschladen F, Lang K, Drell TL, Joseph J
and Zaenker KS: Neurotransmitters are regulators for the migration
of tumor cells and leukocytes. Cancer Immunol Immunother.
51:467–482. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Masur K, Niggemann B, Zanker KS and
Entschladen F: Norepinephrine-induced migration of SW 480 colon
carcinoma cells is inhibited by beta-blockers. Cancer Res.
61:2866–2869. 2001.PubMed/NCBI
|
|
120
|
Drell TT, Joseph J, Lang K, Niggemann B,
Zaenker KS and Entschladen F: Effects of neurotransmitters on the
chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma
cells. Breast Cancer Res Treat. 80:63–70. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Joseph J, Niggemann B, Zaenker KS and
Entschladen F: The neurotransmitter gamma-aminobutyric acid is an
inhibitory regulator for the migration of SW 480 colon carcinoma
cells. Cancer Res. 62:6467–6469. 2002.PubMed/NCBI
|
|
122
|
Watanabe M, Maemura K, Kanbara K, Tamayama
T and Hayasaki H: GABA and GABA receptors in the central nervous
system and other organs. Int Rev Cytol. 213:1–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Miller RJ, Rostene W, Apartis E, Banisadr
G, Biber K, Milligan ED, White FA and Zhang J: Chemokine action in
the nervous system. J Neurosci. 28:11792–11795. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Zhang N and Oppenheim JJ: Crosstalk
between chemokines and neuronal receptors bridges immune and
nervous systems. J Leukoc Biol. 78:1210–1214. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Muller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL,
Mohar A, Verastegui E and Zlotnik A: Involvement of chemokine
receptors in breast cancer metastasis. Nature. 410:50–56. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar
|
|
127
|
Singh S, Sadanandam A and Singh RK:
Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis
Rev. 26:453–467. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Weiss L: Cancer cell traffic from the
lungs to the liver: an example of metastatic inefficiency. Int J
Cancer. 25:385–392. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Weiss L: Deformation-driven, lethal damage
to cancer cells. Its contribution to metastatic inefficiency. Cell
Biophys. 18:73–79. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Bacac M and Stamenkovic I: Metastatic
cancer cell. Annu Rev Pathol. 3:221–247. 2008. View Article : Google Scholar
|
|
131
|
Brain SD: Sensory neuropeptides: their
role in inflammation and wound healing. Immunopharmacology.
37:133–152. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Ishihara K, Kamata M, Hayashi I, Yamashina
S and Majima M: Roles of bradykinin in vascular permeability and
angiogenesis in solid tumor. Int Immunopharmacol. 2:499–509. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
133
|
O'Connor TM, O'Connell J, O'Brien DI,
Goode T, Bredin CP and Shanahan F: The role of substance P in
inflammatory disease. J Cell Physiol. 201:167–180. 2004.
|
|
134
|
Marchesi F, Piemonti L, Mantovani A and
Allavena P: Molecular mechanisms of perineural invasion, a
forgotten pathway of dissemination and metastasis. Cytokine Growth
Factor Rev. 21:77–82. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Jhawer M, Coit D, Brennan M, Qin LX, Gonen
M, Klimstra D, Tang L, Kelsen DP and Shah MA: Perineural invasion
after preoperative chemotherapy predicts poor survival in patients
with locally advanced gastric cancer: gene expression analysis with
pathologic validation. Am J Clin Oncol. 32:356–362. 2009.
View Article : Google Scholar
|
|
136
|
Bilici A, Seker M, Ustaalioglu BB, Kefeli
U, Yildirim E, Yavuzer D, Aydin FM, Salepci T, Oncel M and Gumus M:
Prognostic significance of perineural invasion in patients with
gastric cancer who underwent curative resection. Ann Surg Oncol.
17:2037–2044. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Ceyhan GO, Liebl F, Maak M, Schuster T,
Becker K, Langer R, Demir IE, Hartel M, Friess H and Rosenberg R:
The severity of neural invasion is a crucial prognostic factor in
rectal cancer independent of neoadjuvant radiochemotherapy. Ann
Surg. 252:797–804. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Binmadi NO and Basile JR: Perineural
invasion in oral squamous cell carcinoma: a discussion of
significance and review of the literature. Oral Oncol.
47:1005–1010. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Tai SK, Li WY, Chu PY, Chang SY, Tsai TL,
Wang YF and Huang JL: Risks and clinical implications of perineural
invasion in T1-2 oral tongue squamous cell carcinoma. Head Neck.
34:994–1001. 2011.PubMed/NCBI
|
|
140
|
Miller ME, Palla B, Chen Q, Elashoff DA,
Abemayor E, St John JM and Lai CK: A novel classification system
for perineural invasion in noncutaneous head and neck squamous cell
carcinoma: histologic subcategories and patient outcomes. Am J
Otolaryngol. 33:212–215. 2012. View Article : Google Scholar
|
|
141
|
Hibi T, Mori T, Fukuma M, Yamazaki K,
Hashiguchi A, Yamada T, Tanabe M, Aiura K, Kawakami T, Ogiwara A,
Kosuge T, Kitajima M, Kitagawa Y and Sakamoto M: Synuclein-gamma is
closely involved in perineural invasion and distant metastasis in
mouse models and is a novel prognostic factor in pancreatic cancer.
Clin Cancer Res. 15:2864–2871. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Karak SG, Quatrano N, Buckley J and Ricci
AJ: Prevalence and significance of perineural invasion in invasive
breast carcinoma. Conn Med. 74:17–21. 2010.PubMed/NCBI
|
|
143
|
Meinel A, Fischer U, Bilek K, Hentschel B
and Horn LC: Morphological parameters associated with perineural
invasion (PNI) in carcinoma of the cervix uteri. Int J Surg Pathol.
19:159–163. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Bixby JL and Harris WA: Molecular
mechanisms of axon growth and guidance. Annu Rev Cell Biol.
7:117–159. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Goldberg JL: How does an axon grow? Genes
Dev. 17:941–958. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Pasterkamp RJ, Peschon JJ, Spriggs MK and
Kolodkin AL: Semaphorin 7A promotes axon outgrowth through
integrins and MAPKs. Nature. 424:398–405. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Chilton JK: Molecular mechanisms of axon
guidance. Dev Biol. 292:13–24. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Winckler B: BDNF instructs the kinase LKB1
to grow an axon. Cell. 129:459–460. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Artigiani S, Comoglio PM and Tamagnone L:
Plexins, semaphorins, and scatter factor receptors: a common root
for cell guidance signals? Iubmb Life. 48:477–482. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Iwahashi N, Nagasaka T, Tezel G, Iwashita
T, Asai N, Murakumo Y, Kiuchi K, Sakata K, Nimura Y and Takahashi
M: Expression of glial cell line-derived neurotrophic factor
correlates with perineural invasion of bile duct carcinoma. Cancer.
94:167–174. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Tomaselli KJ, Reichardt LF and Bixby JL:
Distinct molecular interactions mediate neuronal process outgrowth
on nonneuronal cell surfaces and extracellular matrices. J Cell
Biol. 103:2659–2672. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Folkman J: Role of angiogenesis in tumor
growth and metastasis. Semin Oncol. 29:15–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Hillen F and Griffioen AW: Tumour
vascularization: sprouting angiogenesis and beyond. Cancer
Metastasis Rev. 26:489–502. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Weis SM and Cheresh DA: Tumor
angiogenesis: molecular pathways and therapeutic targets. Nat Med.
17:1359–1370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Lutgendorf SK, Cole S, Costanzo E, Bradley
S, Coffin J, Jabbari S, Rainwater K, Ritchie JM, Yang M and Sood
AK: Stress-related mediators stimulate vascular endothelial growth
factor secretion by two ovarian cancer cell lines. Clin Cancer Res.
9:4514–4521. 2003.PubMed/NCBI
|
|
156
|
Thaker PH, Han LY, Kamat AA, Arevalo JM,
Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori
M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN,
Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM,
Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW and Sood AK:
Chronic stress promotes tumor growth and angiogenesis in a mouse
model of ovarian carcinoma. Nat Med. 12:939–944. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Tilan J and Kitlinska J: Sympathetic
neurotransmitters and tumor angiogenesis - link between stress and
cancer progression. J Oncol. 5397062010.PubMed/NCBI
|
|
158
|
Park SY, Kang JH, Jeong KJ, Lee J, Han JW,
Choi WS, Kim YK, Kang J, Park CG and Lee HY: Norepinephrine induces
VEGF expression and angiogenesis by a hypoxia-inducible factor-1α
protein-dependent mechanism. Int J Cancer. 128:2306–2316.
2011.PubMed/NCBI
|
|
159
|
Chakroborty D, Sarkar C, Basu B, Dasgupta
PS and Basu S: Catecholamines regulate tumor angiogenesis. Cancer
Res. 69:3727–3730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Chakroborty D, Sarkar C, Mitra RB,
Banerjee S, Dasgupta PS and Basu S: Depleted dopamine in gastric
cancer tissues: dopamine treatment retards growth of gastric cancer
by inhibiting angiogenesis. Clin Cancer Res. 10:4349–4356. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Basu S, Nagy JA, Pal S, Vasile E,
Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF and
Mukhopadhyay D: The neurotransmitter dopamine inhibits angiogenesis
induced by vascular permeability factor/vascular endothelial growth
factor. Nat Med. 7:569–574. 2001. View
Article : Google Scholar
|
|
162
|
Lutgendorf SK, DeGeest K, Dahmoush L,
Farley D, Penedo F, Bender D, Goodheart M, Buekers TE, Mendez L,
Krueger G, Clevenger L, Lubaroff DM, Sood AK and Cole SW: Social
isolation is associated with elevated tumor norepinephrine in
ovarian carcinoma patients. Brain Behav Immun. 25:250–255. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Basile JR, Castilho RM, Williams VP and
Gutkind JS: Semaphorin 4D provides a link between axon guidance
processes and tumor-induced angiogenesis. Proc Natl Acad Sci USA.
103:9017–9022. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Kigel B, Rabinowicz N, Varshavsky A,
Kessler O and Neufeld G: Plexin-A4 promotes tumor progression and
tumor angiogenesis by enhancement of VEGF and bFGF signaling.
Blood. 118:4285–4296. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Casazza A, Fu X, Johansson I, Capparuccia
L, Andersson F, Giustacchini A, Squadrito ML, Venneri MA, Mazzone
M, Larsson E, Carmeliet P, De Palma M, Naldini L, Tamagnone L and
Rolny C: Systemic and targeted delivery of semaphorin 3A inhibits
tumor angiogenesis and progression in mouse tumor models.
Arterioscler Thromb Vasc Biol. 31:741–749. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Sakurai A, Doci C and Gutkind JS:
Semaphorin signaling in angiogenesis, lymphangiogenesis and cancer.
Cell Res. 22:23–32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Toda M, Suzuki T, Hosono K, Hayashi I,
Hashiba S, Onuma Y, Amano H, Kurihara Y, Kurihara H, Okamoto H,
Hoka S and Majima M: Neuronal system-dependent facilitation of
tumor angiogenesis and tumor growth by calcitonin gene-related
peptide. Proc Natl Acad Sci USA. 105:13550–13555. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Lee EW, Michalkiewicz M, Kitlinska J,
Kalezic I, Switalska H, Yoo P, Sangkharat A, Ji H, Li L,
Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS and
Zukowska Z: Neuropeptide Y induces ischemic angiogenesis and
restores function of ischemic skeletal muscles. J Clin Invest.
111:1853–1862. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Filipski E and Levi F: Circadian
disruption in experimental cancer processes. Integr Cancer Ther.
8:298–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Goodwin AM and D'Amore PA: Wnt signaling
in the vasculature. Angiogenesis. 5:1–9. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Masckauchan TN and Kitajewski J:
Wnt/Frizzled signaling in the vasculature: new angiogenic factors
in sight. Physiology (Bethesda). 21:181–188. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Adams RH and Eichmann A: Axon guidance
molecules in vascular patterning. Cold Spring Harb Perspect Biol.
2:a18752010. View Article : Google Scholar
|
|
173
|
Melani M and Weinstein BM: Common factors
regulating patterning of the nervous and vascular systems. Annu Rev
Cell Dev Biol. 26:639–665. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Carmeliet P and Tessier-Lavigne M: Common
mechanisms of nerve and blood vessel wiring. Nature. 436:193–200.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Entschladen F, Palm D, Drell TT, Lang K
and Zaenker KS: Connecting a tumor to the environment. Curr Pharm
Des. 13:3440–3444. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Capparuccia L and Tamagnone L: Semaphorin
signaling in cancer cells and in cells of the tumor
microenvironment - two sides of a coin. J Cell Sci. 122:1723–1736.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Schirrmacher V, Fogel M, Russmann E,
Bosslet K, Altevogt P and Beck L: Antigenic variation in cancer
metastasis: immune escape versus immune control. Cancer Metastasis
Rev. 1:241–274. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Tan W, Zhang W, Strasner A, Grivennikov S,
Cheng JQ, Hoffman RM and Karin M: Tumour-infiltrating regulatory T
cells stimulate mammary cancer metastasis through RANKL-RANK
signalling. Nature. 470:548–553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Rabin BS, Cohen S, Ganguli R, Lysle DT and
Cunnick JE: Bidirectional interaction between the central nervous
system and the immune system. Crit Rev Immunol. 9:279–312.
1989.PubMed/NCBI
|
|
180
|
Steinman L: Connections between the immune
system and the nervous system. Proc Natl Acad Sci USA.
90:7912–7914. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar
|
|
182
|
Lin WW and Karin M: A cytokine-mediated
link between innate immunity, inflammation, and cancer. J Clin
Invest. 117:1175–1183. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Karin M and Greten FR: NF-kappaB: linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Ben-Eliyahu S, Yirmiya R, Liebeskind JC,
Taylor AN and Gale RP: Stress increases metastatic spread of a
mammary tumor in rats: evidence for mediation by the immune system.
Brain Behav Immun. 5:193–205. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Ben-Eliyahu S, Page GG, Yirmiya R and
Shakhar G: Evidence that stress and surgical interventions promote
tumor development by suppressing natural killer cell activity. Int
J Cancer. 80:880–888. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Levy SM, Herberman RB, Lippman M, D'Angelo
T and Lee J: Immunological and psychosocial predictors of disease
recurrence in patients with early-stage breast cancer. Behav Med.
17:67–75. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Logan RW and Sarkar DK: Circadian nature
of immune function. Mol Cell Endocrinol. 349:82–90. 2012.
View Article : Google Scholar
|
|
188
|
Rana S and Mahmood S: Circadian rhythm and
its role in malignancy. J Circadian Rhythms. 8:32010. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Kiecolt-Glaser JK and Glaser R:
Psychoneuroimmunology and cancer: fact or fiction? Eur J Cancer.
35:1603–1607. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Tracey KJ: The inflammatory reflex.
Nature. 420:853–859. 2002. View Article : Google Scholar
|
|
191
|
Libert C: Inflammation: A nervous
connection. Nature. 421:328–329. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Rosas-Ballina M and Tracey KJ: Cholinergic
control of inflammation. J Intern Med. 265:663–679. 2009.
View Article : Google Scholar
|
|
193
|
Rosenberger P, Schwab JM, Mirakaj V,
Masekowsky E, Mager A, Morote-Garcia JC, Unertl K and Eltzschig HK:
Hypoxia-inducible factor-dependent induction of netrin-1 dampens
inflammation caused by hypoxia. Nat Immunol. 10:195–202. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Tracey KJ: Reflex control of immunity. Nat
Rev Immunol. 9:418–428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Van Der Zanden EP, Boeckxstaens GE and de
Jonge WJ: The vagus nerve as a modulator of intestinal
inflammation. Neurogastroenterol Motil. 21:6–17. 2009.PubMed/NCBI
|
|
196
|
Ley S, Weigert A and Brune B:
Neuromediators in inflammation - a macrophage/nerve connection.
Immunobiology. 215:674–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Meregnani J, Clarencon D, Vivier M,
Peinnequin A, Mouret C, Sinniger V, Picq C, Job A, Canini F,
Jacquier-Sarlin M and Bonaz B: Anti-inflammatory effect of vagus
nerve stimulation in a rat model of inflammatory bowel disease.
Auton Neurosci. 160:82–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Pohanka M, Snopkova S, Havlickova K,
Bostik P, Sinkorova Z, Fusek J, Kuca K and Pikula J:
Macrophage-assisted inflammation and pharmacological regulation of
the cholinergic anti-inflammatory pathway. Curr Med Chem.
18:539–551. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Cerejeira J, Nogueira V, Luis P, Vaz-Serra
A and Mukaetova-Ladinska EB: The cholinergic system and
inflammation: common pathways in delirium pathophysiology. J Am
Geriatr Soc. 60:669–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Peterson CY, Krzyzaniak M, Coimbra R and
Chang DC: Vagus nerve and postinjury inflammatory response. Arch
Surg. 147:76–80. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Kiecolt-Glaser JK, Preacher KJ, MacCallum
RC, Atkinson C, Malarkey WB and Glaser R: Chronic stress and
age-related increases in the proinflammatory cytokine IL-6. Proc
Natl Acad Sci USA. 100:9090–9095. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Madden KS, Szpunar MJ and Brown EB:
beta-Adrenergic receptors (beta-AR) regulate VEGF and IL-6
production by divergent pathways in high beta-AR-expressing breast
cancer cell lines. Breast Cancer Res Treat. 130:747–758. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Yang EV, Kim SJ, Donovan EL, Chen M, Gross
AC, Webster MJ, Barsky SH and Glaser R: Norepinephrine upregulates
VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines:
implications for stress-related enhancement of tumor progression.
Brain Behav Immun. 23:267–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Stathopoulos GT, Sherrill TP, Han W,
Sadikot RT, Yull FE, Blackwell TS and Fingleton B: Host nuclear
factor-kappaB activation potentiates lung cancer metastasis. Mol
Cancer Res. 6:364–371. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Paradisi A and Mehlen P: Netrin-1, a
missing link between chronic inflammation and tumor progression.
Cell Cycle. 9:1253–1262. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Pantel K and Brakenhoff RH: Dissecting the
metastatic cascade. Nat Rev Cancer. 4:448–456. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Rafii S, Lyden D, Benezra R, Hattori K and
Heissig B: Vascular and haematopoietic stem cells: novel targets
for anti-angiogenesis therapy? Nat Rev Cancer. 2:826–835. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Direkze NC, Hodivala-Dilke K, Jeffery R,
Hunt T, Poulsom R, Oukrif D, Alison MR and Wright NA: Bone marrow
contribution to tumor-associated myofibroblasts and fibroblasts.
Cancer Res. 64:8492–8495. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Ishii G, Sangai T, Oda T, Aoyagi Y, Hasebe
T, Kanomata N, Endoh Y, Okumura C, Okuhara Y, Magae J, Emura M,
Ochiya T and Ochiai A: Bone-marrow-derived myofibroblasts
contribute to the cancer-induced stromal reaction. Biochem Biophys
Res Commun. 309:232–240. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Psaila B and Lyden D: The metastatic
niche: adapting the foreign soil. Nat Rev Cancer. 9:285–293. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Kaplan RN, Riba RD, Zacharoulis S, Bramley
AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA,
Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D,
Shmelkov SV, Jensen KK, Rafii S and Lyden D: VEGFR1-positive
haematopoietic bone marrow progenitors initiate the pre-metastatic
niche. Nature. 438:820–827. 2005. View Article : Google Scholar
|
|
212
|
Miyan JA, Broome CS and Whetton AD: Neural
regulation of bone marrow. Blood. 92:2971–2973. 1998.PubMed/NCBI
|
|
213
|
Canaani J, Kollet O and Lapidot T: Neural
regulation of bone, marrow, and the microenvironment. Front Biosci.
3:1021–1031. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
214
|
Benestad HB, Strom-Gundersen I, Iversen
PO, Haug E and Nja A: No neuronal regulation of murine bone marrow
function. Blood. 91:1280–1287. 1998.PubMed/NCBI
|
|
215
|
Artico M, Bosco S, Cavallotti C,
Agostinelli E, Giuliani-Piccari G, Sciorio S, Cocco L and Vitale M:
Noradrenergic and cholinergic innervation of the bone marrow. Int J
Mol Med. 10:77–80. 2002.PubMed/NCBI
|
|
216
|
Imai S, Tokunaga Y, Maeda T, Kikkawa M and
Hukuda S: Calcitonin gene-related peptide, substance P, and
tyrosine hydroxylase-immunoreactive innervation of rat bone
marrows: an immunohistochemical and ultrastructural investigation
on possible efferent and afferent mechanisms. J Orthop Res.
15:133–140. 1997. View Article : Google Scholar
|
|
217
|
Singh D, Joshi DD, Hameed M, Qian J,
Gascon P, Maloof PB, Mosenthal A and Rameshwar P: Increased
expression of preprotachykinin-I and neurokinin receptors in human
breast cancer cells: implications for bone marrow metastasis. Proc
Natl Acad Sci USA. 97:388–393. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Castro TA, Cohen MC and Rameshwar P: The
expression of neurokinin-1 and preprotachykinin-1 in breast cancer
cells depends on the relative degree of invasive and metastatic
potential. Clin Exp Metastasis. 22:621–628. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Lyden D, Hattori K, Dias S, Costa C,
Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y,
Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA,
Manova K, Benezra R and Rafii S: Impaired recruitment of
bone-marrow-derived endothelial and hematopoietic precursor cells
blocks tumor angiogenesis and growth. Nat Med. 7:1194–1201. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Rajantie I, Ilmonen M, Alminaite A,
Ozerdem U, Alitalo K and Salven P: Adult bone marrow-derived cells
recruited during angiogenesis comprise precursors for
periendothelial vascular mural cells. Blood. 104:2084–2086. 2004.
View Article : Google Scholar
|
|
221
|
Chakroborty D, Chowdhury UR, Sarkar C,
Baral R, Dasgupta PS and Basu S: Dopamine regulates endothelial
progenitor cell mobilization from mouse bone marrow in tumor
vascularization. J Clin Invest. 118:1380–1389. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Zhang W: Mesenchymal stem cells in cancer:
friends or foes. Cancer Biol Ther. 7:252–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
223
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Condeelis J and Pollard JW: Macrophages:
obligate partners for tumor cell migration, invasion, and
metastasis. Cell. 124:263–266. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Qian BZ and Pollard JW: Macrophage
diversity enhances tumor progression and metastasis. Cell.
141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
226
|
Maestroni GJ: Catecholaminergic regulation
of hematopoiesis in mice. Blood. 92:2971–2973. 1998.PubMed/NCBI
|
|
227
|
Maestroni GJ: Dendritic cell migration
controlled by alpha 1b-adrenergic receptors. J Immunol.
165:6743–6747. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
228
|
Katayama Y, Battista M, Kao WM, Hidalgo A,
Peired AJ, Thomas SA and Frenette PS: Signals from the sympathetic
nervous system regulate hematopoietic stem cell egress from bone
marrow. Cell. 124:407–421. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
229
|
Mendez-Ferrer S, Lucas D, Battista M and
Frenette PS: Haematopoietic stem cell release is regulated by
circadian oscillations. Nature. 452:442–447. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Bissell MJ and Radisky D: Putting tumours
in context. Nat Rev Cancer. 1:46–54. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Egeblad M, Nakasone ES and Werb Z: Tumors
as organs: complex tissues that interface with the entire organism.
Dev Cell. 18:884–901. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
232
|
Mareel M, Oliveira MJ and Madani I: Cancer
invasion and metastasis: interacting ecosystems. Virchows Arch.
454:599–622. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Ben-Eliyahu S, Shakhar G, Page GG,
Stefanski V and Shakhar K: Suppression of NK cell activity and of
resistance to metastasis by stress: a role for adrenal
catecholamines and beta-adrenoceptors. Neuroimmunomodulat.
8:154–164. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
234
|
Schuller HM, Al-Wadei HA, Ullah MF and
Plummer HK III: Regulation of pancreatic cancer by
neuropsychological stress responses: a novel target for
intervention. Carcinogenesis. 33:191–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
235
|
Yasuniwa Y, Izumi H, Wang KY, Shimajiri S,
Sasaguri Y, Kawai K, Kasai H, Shimada T, Miyake K, Kashiwagi E,
Hirano G, Kidani A, Akiyama M, Han B, Wu Y, Ieiri I, Higuchi S and
Kohno K: Circadian disruption accelerates tumor growth and
angio/stromagenesis through a Wnt signaling pathway. PLoS One.
5:e153302010. View Article : Google Scholar : PubMed/NCBI
|
|
236
|
Arjona A and Sarkar DK: Are circadian
rhythms the code of hypothalamic-immune communication? Insights
from natural killer cells. Neurochem Res. 33:708–718. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
237
|
Filipski E, King VM, Li X, Granda TG,
Mormont MC, Liu X, Claustrat B, Hastings MH and Levi F: Host
circadian clock as a control point in tumor progression. J Natl
Cancer Inst. 94:690–697. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Andersen BL, Kiecolt-Glaser JK and Glaser
R: A biobehavioral model of cancer stress and disease course. Am
Psychol. 49:389–404. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
239
|
Spiegel D: Mind matters in cancer
survival. Psychooncology. 21:588–593. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason
GA, Christensen JG and Kerbel RS: Accelerated metastasis after
short-term treatment with a potent inhibitor of tumor angiogenesis.
Cancer Cell. 15:232–239. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
241
|
Rugo HS: Inhibiting angiogenesis in breast
cancer: the beginning of the end or the end of the beginning? J
Clin Oncol. 30:898–901. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Pàez-Ribes M, Allen E, Hudock J, Takeda T,
Okuyama H and Viñals F: Antiangiogenic therapy elicits malignant
progression of tumors to increased local invasion and distant
metastasis. Cancer Cell. 15:220–231. 2009.PubMed/NCBI
|
|
243
|
Powe DG and Entschladen F: Targeted
therapies: Using beta-blockers to inhibit breast cancer
progression. Nat Rev Clin Oncol. 8:511–512. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
244
|
Barron TI, Connolly RM, Sharp L, Bennett K
and Visvanathan K: Beta blockers and breast cancer mortality: a
population-based study. J Clin Oncol. 29:2635–2644. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
245
|
Syromiatnikov AV and Alistratov AV:
Changes in the efferent impulsation in the vagus nerves during the
metastasis of Lewis lung carcinoma in mice. Eksp Onkol. 11:47–50.
1989.PubMed/NCBI
|
|
246
|
Li ZJ and Cho CH: Neurotransmitters, more
than meets the eye--neurotransmitters and their perspectives in
cancer development and therapy. Eur J Pharmacol. 667:17–22. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
247
|
Schuller HM, Al-Wadei HA and Majidi M:
GABA B receptor is a novel drug target for pancreatic cancer.
Cancer. 112:767–778. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
248
|
Yang ZF, Ho DW, Lam CT, Luk JM, Lum CT, Yu
WC, Poon RT and Fan ST: Identification of brain-derived
neurotrophic factor as a novel functional protein in hepatocellular
carcinoma. Cancer Res. 65:219–225. 2005.PubMed/NCBI
|
|
249
|
Harburg GC and Hinck L: Navigating breast
cancer: axon guidance molecules as breast cancer tumor suppressors
and oncogenes. J Mammary Gland Biol Neoplasia. 16:257–270. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
250
|
Mehlen P, Delloye-Bourgeois C and Chedotal
A: Novel roles for Slits and netrins: axon guidance cues as
anticancer targets? Nat Rev Cancer. 11:188–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
251
|
Welch DR, Cooper CR, Hurst DR, Lynch CC,
Martin MD, Vaidya KS, VanSaun MN and Mastro AM: Metastasis Research
Society-American Association For Cancer Research Joint Conference
on Metastasis. Cancer Res. 68:9578–9582. 2008. View Article : Google Scholar : PubMed/NCBI
|
